1. Home
  2. SAGE vs RNGR Comparison

SAGE vs RNGR Comparison

Compare SAGE & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • RNGR
  • Stock Information
  • Founded
  • SAGE 2010
  • RNGR 2017
  • Country
  • SAGE United States
  • RNGR United States
  • Employees
  • SAGE N/A
  • RNGR N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • RNGR Oilfield Services/Equipment
  • Sector
  • SAGE Health Care
  • RNGR Energy
  • Exchange
  • SAGE Nasdaq
  • RNGR Nasdaq
  • Market Cap
  • SAGE 444.1M
  • RNGR 388.4M
  • IPO Year
  • SAGE 2014
  • RNGR 2017
  • Fundamental
  • Price
  • SAGE $7.50
  • RNGR $14.57
  • Analyst Decision
  • SAGE Hold
  • RNGR Hold
  • Analyst Count
  • SAGE 20
  • RNGR 2
  • Target Price
  • SAGE $10.56
  • RNGR $12.50
  • AVG Volume (30 Days)
  • SAGE 1.6M
  • RNGR 110.6K
  • Earning Date
  • SAGE 04-24-2025
  • RNGR 03-03-2025
  • Dividend Yield
  • SAGE N/A
  • RNGR 1.65%
  • EPS Growth
  • SAGE N/A
  • RNGR N/A
  • EPS
  • SAGE N/A
  • RNGR 0.81
  • Revenue
  • SAGE $41,243,000.00
  • RNGR $571,100,000.00
  • Revenue This Year
  • SAGE $105.47
  • RNGR N/A
  • Revenue Next Year
  • SAGE $67.53
  • RNGR $12.00
  • P/E Ratio
  • SAGE N/A
  • RNGR $18.00
  • Revenue Growth
  • SAGE N/A
  • RNGR N/A
  • 52 Week Low
  • SAGE $4.62
  • RNGR $9.27
  • 52 Week High
  • SAGE $22.18
  • RNGR $18.45
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 60.15
  • RNGR 26.19
  • Support Level
  • SAGE $7.07
  • RNGR $17.08
  • Resistance Level
  • SAGE $7.64
  • RNGR $17.21
  • Average True Range (ATR)
  • SAGE 0.27
  • RNGR 0.71
  • MACD
  • SAGE 0.00
  • RNGR -0.35
  • Stochastic Oscillator
  • SAGE 78.74
  • RNGR 5.83

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About RNGR Ranger Energy Services Inc.

Ranger Energy Services Inc is a provider of onshore high specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions and Ancillary Services, of which key revenue is derived from High Specification Rigs segment.

Share on Social Networks: